BDBM63215 MLS000587490::N-(1,3-benzothiazol-2-yl)-2-(3-cyano-4,5,6-trimethyl-pyridin-2-yl)sulfanyl-ethanamide::N-(1,3-benzothiazol-2-yl)-2-(3-cyano-4,5,6-trimethylpyridin-2-yl)sulfanylacetamide::N-(1,3-benzothiazol-2-yl)-2-[(3-cyano-4,5,6-trimethyl-2-pyridinyl)thio]acetamide::N-(1,3-benzothiazol-2-yl)-2-[(3-cyano-4,5,6-trimethyl-2-pyridyl)thio]acetamide::N-Benzothiazol-2-yl-2-(3-cyano-4,5,6-trimethyl-pyridin-2-ylsulfanyl)-acetamide::SMR000211456::cid_1238357

SMILES Cc1cccc(-c2nn(CC(=O)Nc3cc(F)cc(C(=O)OCCN4CCC4)c3)cc2-c2ccnc3ccccc23)n1

InChI Key InChIKey=DDLVADKFPTZSBI-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 63215   

TargetTGF-beta receptor type-1(Human)
Agomab Spain S.L.U.

US Patent
LigandChemical structure of BindingDB Monomer ID 63215BDBM63215(2-(azetidin-1-yl)ethyl 3-fluoro-5-(2-(3-(6-methylp...)
Affinity DataIC50: 1.00E+3nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent